Applying biosensor development concepts to improve preamplification-free CRISPR/Cas12a-Dx

Area of Science:

• Molecular Biology
• Biotechnology
• Diagnostic Technology

Background:

• CRISPR/Cas-based in vitro diagnostic devices (CRISPR/Cas-Dx) are a significant research area.
• Cas12a enzyme-based diagnostics (Cas12a-Dx) are widely used for DNA target detection.
• Current Cas12a-Dx research often emphasizes preamplification or advanced detection methods, potentially neglecting intrinsic capabilities.

Purpose of the Study:

• To investigate and optimize the intrinsic detection capabilities of Cas12a-Dx without preamplification.
• To systematically evaluate parameters influencing Cas12a-Dx sensitivity and reaction time.
• To establish a baseline for improving Cas12a-Dx performance.

Main Methods:

• Utilized a fluorescence-based Cas12a-Dx system as a test platform.
• Systematically evaluated key reaction parameters: Cas12a enzyme, buffer composition, substrate labeling, substrate concentration, and temperature.
• Focused on optimizing signal-to-background ratio and reaction kinetics.

Main Results:

• Identified critical parameters for enhancing Cas12a-Dx performance.
• Achieved a limit of detection (LOD) of 100 fM without preamplification.
• Reduced the time-to-positive result to less than 46 minutes for the achieved LOD.

Conclusions:

• Demonstrated significant improvements in Cas12a-Dx sensitivity and speed through parameter optimization.
• Established a new benchmark for preamplification-free Cas12a-Dx performance.
• Provided a foundational strategy for advancing Cas12a-Dx and other CRISPR/Cas-Dx technologies.